Clinical Trial Update: ComparisiOn of Neointimal coVerage betwEen ZES and EES Using OCT at 3 Months [Phase 4]

View source ↗

Summary

Phase 4 study comparing neointimal coverage between zotarolimus-eluting stents and everolimus-eluting stents using OCT at 3 months in coronary artery disease; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)
• Zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED